Proposed Session Description: The U.S. blood industry is facing a period of rapid change: increasingly complex product mixes (low titer group O whole blood, cold stored platelets, etc.), brittle supply chains, climate-driven disruptions, shifting donor patterns, and increasing expectations for rea- time visibility across clinical and supply chain environments. This session shares results from the 2025 AABB funded Process Development Grant that enabled Circulate’s capacity to provide new, operationally critical signals that help organizations understand and respond to a more dynamic, complex blood supply. Unlike Circulate’s other proposed session which focuses on long-term inventory and donor trends, this presentation centers on specific elements of blood operator data insights developed through the grant and how they augment daily operational readiness and enhance pre-existing data insights. Session Components Emerging products (LTOWB, CSP): Visibility into product mix and adoption matters as hospitals look to blood operators for guidance on products, demand accelerates, and restriction and availability change. This view is available through Circulate’s real-time data and extending back as far as these product types appear, through 2022. Mobile vs. fixed site collections: How differentiating between collection site type creates new insights into donor behavior and flex capacity. This is information with direct implications for blood operator leaders, transfusion providers, and those involved in national-level resiliency and preparedness. Shelf life and shipment insights: A national view on component age, turnover, and shipment behavior that support PBM leaders, transfusion providers, and executives managing risk, cost, and clinical readiness. Blood banking perspective: A representative from one of Circulate’s members will provide perspective on the impact and actionability of these insights.
Why This Matters Now Blood operators are in increasingly fast-paced environment that has enormous pressure externally and internally to change. As disruptions become more frequent and product innovations accelerate, we need real-time operational intelligence to support preparedness and decision making. This session provides attendees with new tools, dimensions of data, and ways of understanding operational dynamics.
Learning Objectives:
Explain how new operational data signals such as emerging product production patterns (LTOWB, CSP, etc.), collection site behavior, and shelf life/shipment insights shape decision making across laboratory practice, PBM programs, and operational leadership.
Interpret specific real time supply chain signals from Circulate’s expanded dataset to understand how they manifest in donation activity and inventory and how these insights support supply chain resilience across healthcare settings.
Demonstrate how the AABB Process Development Grant enabled the creation of new operational data insights and describe how attendees can apply these grant supported capabilities to improve decision making, coordination, and readiness in their own organizations.
